PSDV
pSivida Corp.
NasdaqGM
People also watch:ALIMPRANOPXAONTYBIOD
3.490.00 (0.00%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close3.49
Open3.47
Bid2.99 x 100
Ask3.50 x 300
52wk Range2.37 - 5.81
Day's Range3.47 - 3.49
Volume7,522
Avg Vol (3m)71,706
As of 4:00 PM EDT. Market closed.
  • Capital Cube5 days ago

    ETF’s with exposure to pSivida Corp. : July 20, 2016

    Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to pSivida Corp.Here are 5 ETF’s with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns […] (Read more...) The post ETF’s with exposure to pSivida Corp. : July 20, 2016 appeared first on CapitalCube.

  • pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2016 By the Numbers
    Capital Cube2 months ago

    pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2016 By the Numbers

    Click here to see latest analysispSivida Corp. reports financial results for the quarter ended March 31, 2016.We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc and Pfizer Inc. (NKTR-US, REGN-US, XOMA-US, ABT-US, MRK-US, HRTX-US and […] (Read more...) The post pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2016 By the Numbers appeared first on CapitalCube.